A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Brain Metastases
Interventions: DRUG: Pyrotinib Plus Vinorelbine
Sponsor: Chinese Academy of Medical Sciences